Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey
Burkina Faso, 2017
Get MicrodataCreated on
Dec 05, 2019
Last modified
Dec 05, 2019
Page views
84900
Downloads
116
F7_219_M (f7_219_2)
Data file: f7_jul19
Overview
Valid:
150
Invalid:
0
Type:
Discrete
Start:
535
End:
557
Width:
23
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 2 |
1.3%
|
|
| 00 | 22 |
14.7%
|
|
| 3 | 2 |
1.3%
|
|
| 99 | 1 |
0.7%
|
|
| ACT | 1 |
0.7%
|
|
| AMOXICILLIN | 1 |
0.7%
|
|
| AMOXYCILLINE | 1 |
0.7%
|
|
| Amoxicilline | 3 |
2%
|
|
| Amoxicilline gellule | 1 |
0.7%
|
|
| BITYL CP | 1 |
0.7%
|
|
| Carbocisteïne | 1 |
0.7%
|
|
| Carbotoux sp | 1 |
0.7%
|
|
| Carbotoux sp | 1 |
0.7%
|
|
| Cotrimoxazole comp | 1 |
0.7%
|
|
| Erytromicine | 1 |
0.7%
|
|
| FAF | 1 |
0.7%
|
|
| Fer Acide Folique | 1 |
0.7%
|
|
| HPV | 1 |
0.7%
|
|
| IBUPROFENE | 1 |
0.7%
|
|
| Ibuprofen | 1 |
0.7%
|
|
| Ibuprofene | 1 |
0.7%
|
|
| METRO CP 250MG | 1 |
0.7%
|
|
| Mebendazol cp | 1 |
0.7%
|
|
| Miconazole | 1 |
0.7%
|
|
| Nystatin Pessaries | 1 |
0.7%
|
|
| PARA | 2 |
1.3%
|
|
| PARA 500MG | 1 |
0.7%
|
|
| PARA CP 500MG | 1 |
0.7%
|
|
| Para | 4 |
2.7%
|
|
| Para 500mg | 1 |
0.7%
|
|
| Paracetamol | 6 |
4%
|
|
| Paracetamol cp | 1 |
0.7%
|
|
| Phloro cp | 1 |
0.7%
|
|
| Phloro inj | 1 |
0.7%
|
|
| Phloroglucinol | 1 |
0.7%
|
|
| Quinine | 2 |
1.3%
|
|
| RL 500cc | 1 |
0.7%
|
|
| Tetracycline pomade | 1 |
0.7%
|
|
| albendazole | 1 |
0.7%
|
|
| aluminium hydroxide | 1 |
0.7%
|
|
| amoxi cp | 1 |
0.7%
|
|
| amoxicilin | 1 |
0.7%
|
|
| amoxicilline | 2 |
1.3%
|
|
| amoxicilline comp | 2 |
1.3%
|
|
| ampicilline | 1 |
0.7%
|
|
| artesunate amodiaquine | 1 |
0.7%
|
|
| arthemeter lumefantrine | 1 |
0.7%
|
|
| butylbromide | 1 |
0.7%
|
|
| carbotoux | 1 |
0.7%
|
|
| carbotoux sirop | 1 |
0.7%
|
|
| ceftri | 1 |
0.7%
|
|
| ceftriaxone | 1 |
0.7%
|
|
| chlorphenamine | 1 |
0.7%
|
|
| complex b | 1 |
0.7%
|
|
| ctri | 1 |
0.7%
|
|
| diclofenac | 1 |
0.7%
|
|
| doxicycline | 1 |
0.7%
|
|
| fer | 1 |
0.7%
|
|
| furosemide | 1 |
0.7%
|
|
| hydroxide d'aluminium | 1 |
0.7%
|
|
| hyoscine | 1 |
0.7%
|
|
| ibuprofen | 1 |
0.7%
|
|
| ibuprofene | 2 |
1.3%
|
|
| kit fievre | 1 |
0.7%
|
|
| lumartem | 1 |
0.7%
|
|
| mebendazole | 1 |
0.7%
|
|
| mebendazole cp | 1 |
0.7%
|
|
| metoclopramide | 1 |
0.7%
|
|
| metronidazole | 1 |
0.7%
|
|
| multivitamin comp | 1 |
0.7%
|
|
| multivitamine | 1 |
0.7%
|
|
| nystatin | 1 |
0.7%
|
|
| nystatine ovules | 1 |
0.7%
|
|
| par a | 1 |
0.7%
|
|
| para | 9 |
6%
|
|
| para comp | 1 |
0.7%
|
|
| para cp | 2 |
1.3%
|
|
| paracetamol | 6 |
4%
|
|
| paracetamol 500mg | 1 |
0.7%
|
|
| paracetamol comp | 1 |
0.7%
|
|
| paracetamole | 4 |
2.7%
|
|
| paregorique cp | 1 |
0.7%
|
|
| peni v | 1 |
0.7%
|
|
| phloroglicinol | 1 |
0.7%
|
|
| phloroglucinol | 1 |
0.7%
|
|
| phloroglucinol cp | 2 |
1.3%
|
|
| phloroglucinole cp | 1 |
0.7%
|
|
| phlotoglucinol | 1 |
0.7%
|
|
| quinine | 2 |
1.3%
|
|
| quinine 300 | 1 |
0.7%
|
|
| quinine sulfate | 1 |
0.7%
|
|
| sparadran | 1 |
0.7%
|
|
| sulfamethoxazole | 1 |
0.7%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.